ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Ertapenem Sodium for Injection Market Research Report 2026
Published Date: 2026-01-23
|
Report Code: QYRE-Auto-25Q18391
Home | Market Reports | Business & Industrial| Chemicals Industry
Global Ertapenem Sodium for Injection Market Research Report 2024
BUY CHAPTERS

Global Ertapenem Sodium for Injection Market Research Report 2026

Code: QYRE-Auto-25Q18391
Report
2026-01-23
Pages:120
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Chongqing Shenghuaxi Pharmaceutical Co., Ltd
Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.
ACS DOBFAR SPA
NorthStar Rx
Par Pharmaceutical
Intelicure Lifesciences
Qilu Anti Pharmaceutical Co., Ltd.
Hainan Herui Pharmaceutical Co., Ltd.
Sichuan Pharmaceutical Preparation Co., Ltd.
EUGIA PHARMA INC
Unitech Biotech

Ertapenem Sodium for Injection Market Size

The global Ertapenem Sodium for Injection market was valued at US$ 933 million in 2025 and is anticipated to reach US$ 1450 million by 2032, at a CAGR of 6.6% from 2026 to 2032.

Ertapenem Sodium for Injection Market

Ertapenem Sodium for Injection Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Ertapenem Sodium for Injection competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Ertapenem Sodium for Injection is a broad-spectrum antibiotic belonging to the carbapenem class of antibacterial drugs. It is administered by intravenous or intramuscular injection and is used to treat a variety of infections caused by sensitive bacteria. Ertapenem Sodium has a broad antibacterial spectrum and has good antibacterial activity against many Gram-positive and Gram-negative bacteria, as well as some anaerobic bacteria.
The North American market for Ertapenem Sodium for Injection is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Ertapenem Sodium for Injection is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Ertapenem Sodium for Injection include Chongqing Shenghuaxi Pharmaceutical Co., Ltd., Qilu Anti Pharmaceutical Co., Ltd., Hainan Herui Pharmaceutical Co., Ltd., Sichuan Pharmaceutical Preparation Co., Ltd., Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd., ACS DOBFAR SPA, EUGIA PHARMA INC, Unitech Biotech, NorthStar Rx, Par Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Ertapenem Sodium for Injection market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Ertapenem Sodium for Injection. The Ertapenem Sodium for Injection market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Ertapenem Sodium for Injection market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Ertapenem Sodium for Injection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Ertapenem Sodium for Injection Market Report

Report Metric Details
Report Name Ertapenem Sodium for Injection Market
Accounted market size in 2025 US$ 933 in million
Forecasted market size in 2032 US$ 1450 million
CAGR 6.6%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • 0.5g
  • 1g
by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Chongqing Shenghuaxi Pharmaceutical Co., Ltd., Qilu Anti Pharmaceutical Co., Ltd., Hainan Herui Pharmaceutical Co., Ltd., Sichuan Pharmaceutical Preparation Co., Ltd., Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd., ACS DOBFAR SPA, EUGIA PHARMA INC, Unitech Biotech, NorthStar Rx, Par Pharmaceutical, Intelicure Lifesciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Ertapenem Sodium for Injection manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Ertapenem Sodium for Injection sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Ertapenem Sodium for Injection Market growing?

Ans: The Ertapenem Sodium for Injection Market witnessing a CAGR of 6.6% during the forecast period 2026-2032.

What is the Ertapenem Sodium for Injection Market size in 2032?

Ans: The Ertapenem Sodium for Injection Market size in 2032 will be US$ 1450 million.

Who are the main players in the Ertapenem Sodium for Injection Market report?

Ans: The main players in the Ertapenem Sodium for Injection Market are Chongqing Shenghuaxi Pharmaceutical Co., Ltd., Qilu Anti Pharmaceutical Co., Ltd., Hainan Herui Pharmaceutical Co., Ltd., Sichuan Pharmaceutical Preparation Co., Ltd., Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd., ACS DOBFAR SPA, EUGIA PHARMA INC, Unitech Biotech, NorthStar Rx, Par Pharmaceutical, Intelicure Lifesciences

What are the Application segmentation covered in the Ertapenem Sodium for Injection Market report?

Ans: The Applications covered in the Ertapenem Sodium for Injection Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Ertapenem Sodium for Injection Market report?

Ans: The Types covered in the Ertapenem Sodium for Injection Market report are 0.5g, 1g

1 Ertapenem Sodium for Injection Market Overview
1.1 Product Definition
1.2 Ertapenem Sodium for Injection by Type
1.2.1 Global Ertapenem Sodium for Injection Market Value by Type: 2025 vs 2032
1.2.2 0.5g
1.2.3 1g
1.3 Ertapenem Sodium for Injection by Application
1.3.1 Global Ertapenem Sodium for Injection Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Ertapenem Sodium for Injection Market Size Estimates and Forecasts
1.4.1 Global Ertapenem Sodium for Injection Revenue 2021–2032
1.4.2 Global Ertapenem Sodium for Injection Sales 2021–2032
1.4.3 Global Ertapenem Sodium for Injection Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Ertapenem Sodium for Injection Market Competition by Manufacturers
2.1 Global Ertapenem Sodium for Injection Sales Market Share by Manufacturers (2021–2026)
2.2 Global Ertapenem Sodium for Injection Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Ertapenem Sodium for Injection Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Ertapenem Sodium for Injection, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Ertapenem Sodium for Injection, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Ertapenem Sodium for Injection, Product Types and Applications
2.7 Global Key Manufacturers of Ertapenem Sodium for Injection, Date of Entry into the Industry
2.8 Global Ertapenem Sodium for Injection Market Competitive Situation and Trends
2.8.1 Global Ertapenem Sodium for Injection Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Ertapenem Sodium for Injection Players Market Share by Revenue
2.8.3 Global Ertapenem Sodium for Injection Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Ertapenem Sodium for Injection Market Scenario by Region
3.1 Global Ertapenem Sodium for Injection Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Ertapenem Sodium for Injection Sales by Region: 2021–2032
3.2.1 Global Ertapenem Sodium for Injection Sales by Region: 2021–2026
3.2.2 Global Ertapenem Sodium for Injection Sales by Region: 2027–2032
3.3 Global Ertapenem Sodium for Injection Revenue by Region: 2021–2032
3.3.1 Global Ertapenem Sodium for Injection Revenue by Region: 2021–2026
3.3.2 Global Ertapenem Sodium for Injection Revenue by Region: 2027–2032
3.4 North America Ertapenem Sodium for Injection Market Facts & Figures by Country
3.4.1 North America Ertapenem Sodium for Injection Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Ertapenem Sodium for Injection Sales by Country (2021–2032)
3.4.3 North America Ertapenem Sodium for Injection Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Ertapenem Sodium for Injection Market Facts & Figures by Country
3.5.1 Europe Ertapenem Sodium for Injection Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Ertapenem Sodium for Injection Sales by Country (2021–2032)
3.5.3 Europe Ertapenem Sodium for Injection Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ertapenem Sodium for Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Ertapenem Sodium for Injection Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Ertapenem Sodium for Injection Sales by Region (2021–2032)
3.6.3 Asia Pacific Ertapenem Sodium for Injection Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Ertapenem Sodium for Injection Market Facts & Figures by Country
3.7.1 Latin America Ertapenem Sodium for Injection Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Ertapenem Sodium for Injection Sales by Country (2021–2032)
3.7.3 Latin America Ertapenem Sodium for Injection Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Ertapenem Sodium for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Ertapenem Sodium for Injection Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Ertapenem Sodium for Injection Sales by Country (2021–2032)
3.8.3 Middle East and Africa Ertapenem Sodium for Injection Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Ertapenem Sodium for Injection Sales by Type (2021–2032)
4.1.1 Global Ertapenem Sodium for Injection Sales by Type (2021–2026)
4.1.2 Global Ertapenem Sodium for Injection Sales by Type (2027–2032)
4.1.3 Global Ertapenem Sodium for Injection Sales Market Share by Type (2021–2032)
4.2 Global Ertapenem Sodium for Injection Revenue by Type (2021–2032)
4.2.1 Global Ertapenem Sodium for Injection Revenue by Type (2021–2026)
4.2.2 Global Ertapenem Sodium for Injection Revenue by Type (2027–2032)
4.2.3 Global Ertapenem Sodium for Injection Revenue Market Share by Type (2021–2032)
4.3 Global Ertapenem Sodium for Injection Price by Type (2021–2032)
5 Segment by Application
5.1 Global Ertapenem Sodium for Injection Sales by Application (2021–2032)
5.1.1 Global Ertapenem Sodium for Injection Sales by Application (2021–2026)
5.1.2 Global Ertapenem Sodium for Injection Sales by Application (2027–2032)
5.1.3 Global Ertapenem Sodium for Injection Sales Market Share by Application (2021–2032)
5.2 Global Ertapenem Sodium for Injection Revenue by Application (2021–2032)
5.2.1 Global Ertapenem Sodium for Injection Revenue by Application (2021–2026)
5.2.2 Global Ertapenem Sodium for Injection Revenue by Application (2027–2032)
5.2.3 Global Ertapenem Sodium for Injection Revenue Market Share by Application (2021–2032)
5.3 Global Ertapenem Sodium for Injection Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Chongqing Shenghuaxi Pharmaceutical Co., Ltd.
6.1.1 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Company Information
6.1.2 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Description and Business Overview
6.1.3 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio
6.1.5 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Recent Developments/Updates
6.2 Qilu Anti Pharmaceutical Co., Ltd.
6.2.1 Qilu Anti Pharmaceutical Co., Ltd. Company Information
6.2.2 Qilu Anti Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 Qilu Anti Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Qilu Anti Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio
6.2.5 Qilu Anti Pharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Hainan Herui Pharmaceutical Co., Ltd.
6.3.1 Hainan Herui Pharmaceutical Co., Ltd. Company Information
6.3.2 Hainan Herui Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Hainan Herui Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Hainan Herui Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio
6.3.5 Hainan Herui Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 Sichuan Pharmaceutical Preparation Co., Ltd.
6.4.1 Sichuan Pharmaceutical Preparation Co., Ltd. Company Information
6.4.2 Sichuan Pharmaceutical Preparation Co., Ltd. Description and Business Overview
6.4.3 Sichuan Pharmaceutical Preparation Co., Ltd. Ertapenem Sodium for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Sichuan Pharmaceutical Preparation Co., Ltd. Ertapenem Sodium for Injection Product Portfolio
6.4.5 Sichuan Pharmaceutical Preparation Co., Ltd. Recent Developments/Updates
6.5 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.
6.5.1 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Company Information
6.5.2 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Description and Business Overview
6.5.3 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio
6.5.5 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Recent Developments/Updates
6.6 ACS DOBFAR SPA
6.6.1 ACS DOBFAR SPA Company Information
6.6.2 ACS DOBFAR SPA Description and Business Overview
6.6.3 ACS DOBFAR SPA Ertapenem Sodium for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 ACS DOBFAR SPA Ertapenem Sodium for Injection Product Portfolio
6.6.5 ACS DOBFAR SPA Recent Developments/Updates
6.7 EUGIA PHARMA INC
6.7.1 EUGIA PHARMA INC Company Information
6.7.2 EUGIA PHARMA INC Description and Business Overview
6.7.3 EUGIA PHARMA INC Ertapenem Sodium for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 EUGIA PHARMA INC Ertapenem Sodium for Injection Product Portfolio
6.7.5 EUGIA PHARMA INC Recent Developments/Updates
6.8 Unitech Biotech
6.8.1 Unitech Biotech Company Information
6.8.2 Unitech Biotech Description and Business Overview
6.8.3 Unitech Biotech Ertapenem Sodium for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Unitech Biotech Ertapenem Sodium for Injection Product Portfolio
6.8.5 Unitech Biotech Recent Developments/Updates
6.9 NorthStar Rx
6.9.1 NorthStar Rx Company Information
6.9.2 NorthStar Rx Description and Business Overview
6.9.3 NorthStar Rx Ertapenem Sodium for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 NorthStar Rx Ertapenem Sodium for Injection Product Portfolio
6.9.5 NorthStar Rx Recent Developments/Updates
6.10 Par Pharmaceutical
6.10.1 Par Pharmaceutical Company Information
6.10.2 Par Pharmaceutical Description and Business Overview
6.10.3 Par Pharmaceutical Ertapenem Sodium for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Par Pharmaceutical Ertapenem Sodium for Injection Product Portfolio
6.10.5 Par Pharmaceutical Recent Developments/Updates
6.11 Intelicure Lifesciences
6.11.1 Intelicure Lifesciences Company Information
6.11.2 Intelicure Lifesciences Description and Business Overview
6.11.3 Intelicure Lifesciences Ertapenem Sodium for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Intelicure Lifesciences Ertapenem Sodium for Injection Product Portfolio
6.11.5 Intelicure Lifesciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ertapenem Sodium for Injection Industry Chain Analysis
7.2 Ertapenem Sodium for Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ertapenem Sodium for Injection Production Mode & Process Analysis
7.4 Ertapenem Sodium for Injection Sales and Marketing
7.4.1 Ertapenem Sodium for Injection Sales Channels
7.4.2 Ertapenem Sodium for Injection Distributors
7.5 Ertapenem Sodium for Injection Customer Analysis
8 Ertapenem Sodium for Injection Market Dynamics
8.1 Ertapenem Sodium for Injection Industry Trends
8.2 Ertapenem Sodium for Injection Market Drivers
8.3 Ertapenem Sodium for Injection Market Challenges
8.4 Ertapenem Sodium for Injection Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Chongqing Shenghuaxi Pharmaceutical Co., Ltd
Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.
ACS DOBFAR SPA
NorthStar Rx
Par Pharmaceutical
Intelicure Lifesciences
Qilu Anti Pharmaceutical Co., Ltd.
Hainan Herui Pharmaceutical Co., Ltd.
Sichuan Pharmaceutical Preparation Co., Ltd.
EUGIA PHARMA INC
Unitech Biotech
List of Tables
 Table 1. Global Ertapenem Sodium for Injection Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Ertapenem Sodium for Injection Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Ertapenem Sodium for Injection Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Ertapenem Sodium for Injection Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Ertapenem Sodium for Injection Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Ertapenem Sodium for Injection Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Ertapenem Sodium for Injection Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Ertapenem Sodium for Injection Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Ertapenem Sodium for Injection, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Ertapenem Sodium for Injection, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Ertapenem Sodium for Injection, Product Types and Applications
 Table 12. Global Key Manufacturers of Ertapenem Sodium for Injection, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Ertapenem Sodium for Injection Companies by Tier (Tier 1, Tier 2, Tier 3), based on Ertapenem Sodium for Injection Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Ertapenem Sodium for Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Ertapenem Sodium for Injection Sales by Region (K Units), 2021–2026
 Table 18. Global Ertapenem Sodium for Injection Sales Market Share by Region (2021–2026)
 Table 19. Global Ertapenem Sodium for Injection Sales by Region (K Units), 2027–2032
 Table 20. Global Ertapenem Sodium for Injection Sales Market Share by Region (2027–2032)
 Table 21. Global Ertapenem Sodium for Injection Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Ertapenem Sodium for Injection Revenue Market Share by Region (2021–2026)
 Table 23. Global Ertapenem Sodium for Injection Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Ertapenem Sodium for Injection Revenue Market Share by Region (2027–2032)
 Table 25. North America Ertapenem Sodium for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Ertapenem Sodium for Injection Sales by Country (K Units), 2021–2026
 Table 27. North America Ertapenem Sodium for Injection Sales by Country (K Units), 2027–2032
 Table 28. North America Ertapenem Sodium for Injection Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Ertapenem Sodium for Injection Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Ertapenem Sodium for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Ertapenem Sodium for Injection Sales by Country (K Units), 2021–2026
 Table 32. Europe Ertapenem Sodium for Injection Sales by Country (K Units), 2027–2032
 Table 33. Europe Ertapenem Sodium for Injection Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Ertapenem Sodium for Injection Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Ertapenem Sodium for Injection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Ertapenem Sodium for Injection Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Ertapenem Sodium for Injection Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Ertapenem Sodium for Injection Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Ertapenem Sodium for Injection Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Ertapenem Sodium for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Ertapenem Sodium for Injection Sales by Country (K Units), 2021–2026
 Table 42. Latin America Ertapenem Sodium for Injection Sales by Country (K Units), 2027–2032
 Table 43. Latin America Ertapenem Sodium for Injection Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Ertapenem Sodium for Injection Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Ertapenem Sodium for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Ertapenem Sodium for Injection Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Ertapenem Sodium for Injection Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Ertapenem Sodium for Injection Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Ertapenem Sodium for Injection Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Ertapenem Sodium for Injection Sales (K Units) by Type (2021–2026)
 Table 51. Global Ertapenem Sodium for Injection Sales (K Units) by Type (2027–2032)
 Table 52. Global Ertapenem Sodium for Injection Sales Market Share by Type (2021–2026)
 Table 53. Global Ertapenem Sodium for Injection Sales Market Share by Type (2027–2032)
 Table 54. Global Ertapenem Sodium for Injection Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Ertapenem Sodium for Injection Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Ertapenem Sodium for Injection Revenue Market Share by Type (2021–2026)
 Table 57. Global Ertapenem Sodium for Injection Revenue Market Share by Type (2027–2032)
 Table 58. Global Ertapenem Sodium for Injection Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Ertapenem Sodium for Injection Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Ertapenem Sodium for Injection Sales (K Units) by Application (2021–2026)
 Table 61. Global Ertapenem Sodium for Injection Sales (K Units) by Application (2027–2032)
 Table 62. Global Ertapenem Sodium for Injection Sales Market Share by Application (2021–2026)
 Table 63. Global Ertapenem Sodium for Injection Sales Market Share by Application (2027–2032)
 Table 64. Global Ertapenem Sodium for Injection Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Ertapenem Sodium for Injection Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Ertapenem Sodium for Injection Revenue Market Share by Application (2021–2026)
 Table 67. Global Ertapenem Sodium for Injection Revenue Market Share by Application (2027–2032)
 Table 68. Global Ertapenem Sodium for Injection Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Ertapenem Sodium for Injection Price (US$/Unit) by Application (2027–2032)
 Table 70. Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Company Information
 Table 71. Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Description and Business Overview
 Table 72. Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product
 Table 74. Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 75. Qilu Anti Pharmaceutical Co., Ltd. Company Information
 Table 76. Qilu Anti Pharmaceutical Co., Ltd. Description and Business Overview
 Table 77. Qilu Anti Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Qilu Anti Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product
 Table 79. Qilu Anti Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 80. Hainan Herui Pharmaceutical Co., Ltd. Company Information
 Table 81. Hainan Herui Pharmaceutical Co., Ltd. Description and Business Overview
 Table 82. Hainan Herui Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Hainan Herui Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product
 Table 84. Hainan Herui Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 85. Sichuan Pharmaceutical Preparation Co., Ltd. Company Information
 Table 86. Sichuan Pharmaceutical Preparation Co., Ltd. Description and Business Overview
 Table 87. Sichuan Pharmaceutical Preparation Co., Ltd. Ertapenem Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Sichuan Pharmaceutical Preparation Co., Ltd. Ertapenem Sodium for Injection Product
 Table 89. Sichuan Pharmaceutical Preparation Co., Ltd. Recent Developments/Updates
 Table 90. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Company Information
 Table 91. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Description and Business Overview
 Table 92. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product
 Table 94. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 95. ACS DOBFAR SPA Company Information
 Table 96. ACS DOBFAR SPA Description and Business Overview
 Table 97. ACS DOBFAR SPA Ertapenem Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. ACS DOBFAR SPA Ertapenem Sodium for Injection Product
 Table 99. ACS DOBFAR SPA Recent Developments/Updates
 Table 100. EUGIA PHARMA INC Company Information
 Table 101. EUGIA PHARMA INC Description and Business Overview
 Table 102. EUGIA PHARMA INC Ertapenem Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. EUGIA PHARMA INC Ertapenem Sodium for Injection Product
 Table 104. EUGIA PHARMA INC Recent Developments/Updates
 Table 105. Unitech Biotech Company Information
 Table 106. Unitech Biotech Description and Business Overview
 Table 107. Unitech Biotech Ertapenem Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Unitech Biotech Ertapenem Sodium for Injection Product
 Table 109. Unitech Biotech Recent Developments/Updates
 Table 110. NorthStar Rx Company Information
 Table 111. NorthStar Rx Description and Business Overview
 Table 112. NorthStar Rx Ertapenem Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. NorthStar Rx Ertapenem Sodium for Injection Product
 Table 114. NorthStar Rx Recent Developments/Updates
 Table 115. Par Pharmaceutical Company Information
 Table 116. Par Pharmaceutical Description and Business Overview
 Table 117. Par Pharmaceutical Ertapenem Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Par Pharmaceutical Ertapenem Sodium for Injection Product
 Table 119. Par Pharmaceutical Recent Developments/Updates
 Table 120. Intelicure Lifesciences Company Information
 Table 121. Intelicure Lifesciences Description and Business Overview
 Table 122. Intelicure Lifesciences Ertapenem Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Intelicure Lifesciences Ertapenem Sodium for Injection Product
 Table 124. Intelicure Lifesciences Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Ertapenem Sodium for Injection Distributors List
 Table 128. Ertapenem Sodium for Injection Customers List
 Table 129. Ertapenem Sodium for Injection Market Trends
 Table 130. Ertapenem Sodium for Injection Market Drivers
 Table 131. Ertapenem Sodium for Injection Market Challenges
 Table 132. Ertapenem Sodium for Injection Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Ertapenem Sodium for Injection
 Figure 2. Global Ertapenem Sodium for Injection Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Ertapenem Sodium for Injection Market Share by Type: 2025 & 2032
 Figure 4. 0.5g Product Picture
 Figure 5. 1g Product Picture
 Figure 6. Global Ertapenem Sodium for Injection Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Ertapenem Sodium for Injection Market Share by Application: 2025 & 2032
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Other
 Figure 11. Global Ertapenem Sodium for Injection Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Ertapenem Sodium for Injection Market Size (US$ Million), 2021–2032
 Figure 13. Global Ertapenem Sodium for Injection Sales (K Units), 2021–2032
 Figure 14. Global Ertapenem Sodium for Injection Average Price (US$/Unit), 2021–2032
 Figure 15. Ertapenem Sodium for Injection Report Years Considered
 Figure 16. Ertapenem Sodium for Injection Sales Share by Manufacturers in 2025
 Figure 17. Global Ertapenem Sodium for Injection Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Ertapenem Sodium for Injection Players: Market Share by Revenue in Ertapenem Sodium for Injection in 2025
 Figure 19. Ertapenem Sodium for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Ertapenem Sodium for Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Ertapenem Sodium for Injection Sales Market Share by Country (2021–2032)
 Figure 22. North America Ertapenem Sodium for Injection Revenue Market Share by Country (2021–2032)
 Figure 23. United States Ertapenem Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Ertapenem Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Ertapenem Sodium for Injection Sales Market Share by Country (2021–2032)
 Figure 26. Europe Ertapenem Sodium for Injection Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Ertapenem Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Ertapenem Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Ertapenem Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Ertapenem Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Ertapenem Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Ertapenem Sodium for Injection Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Ertapenem Sodium for Injection Revenue Market Share by Region (2021–2032)
 Figure 34. China Ertapenem Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Ertapenem Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Ertapenem Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Ertapenem Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Ertapenem Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Ertapenem Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Southeast Asia Ertapenem Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Latin America Ertapenem Sodium for Injection Sales Market Share by Country (2021–2032)
 Figure 42. Latin America Ertapenem Sodium for Injection Revenue Market Share by Country (2021–2032)
 Figure 43. Mexico Ertapenem Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Brazil Ertapenem Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Argentina Ertapenem Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Colombia Ertapenem Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa Ertapenem Sodium for Injection Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa Ertapenem Sodium for Injection Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey Ertapenem Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia Ertapenem Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE Ertapenem Sodium for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of Ertapenem Sodium for Injection by Type (2021–2032)
 Figure 53. Global Revenue Market Share of Ertapenem Sodium for Injection by Type (2021–2032)
 Figure 54. Global Ertapenem Sodium for Injection Price (US$/Unit) by Type (2021–2032)
 Figure 55. Global Sales Market Share of Ertapenem Sodium for Injection by Application (2021–2032)
 Figure 56. Global Revenue Market Share of Ertapenem Sodium for Injection by Application (2021–2032)
 Figure 57. Global Ertapenem Sodium for Injection Price (US$/Unit) by Application (2021–2032)
 Figure 58. Ertapenem Sodium for Injection Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Ertapenem Sodium Market Research Report 2024
Global Ceftizole Sodium for Injection Market Research Report 2024
Global Cefotaxime Sodium Injection Market Research Report 2024
Global Piperacillin Sodium Combination Injection Market Research Report 2024
Global Cefminox Sodium for Injection Market Research Report 2024
Global Piperacillin Sodium and Tazobactam Sodium for Injection Market Research Report 2024
Global Rifamycin Sodium Injection Market Research Report 2024
Global Colistimethate Sodium for Injection Market Research Report 2024
Ertapenem Sodium API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Flucloxacillin Sodium Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Piperacillin Sodium and Sulbactam Sodium for Injection Market Research Report 2024
Global Carbapenem Market Insights Forecast to 2030
Global Mezlocillin Sodium Injection Market Research Report 2024
Global Piperacillin Sodium for Injection Market Research Report 2024
Global Ampicillin Sodium and Sulbactam Sodium For Injection Market Research Report 2024
Antibiotics Piperacillin Sodium Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ertapenem Injection API Market Research Report 2025
Global Pentobarbital Sodium Injection Market Research Report 2024
Cefotaxime Sodium for Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ertapenem for Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions